Introduction Evidence from a number of open-label, uncontrolled studies has suggested that
rituximab may benefit patients with autoimmune diseases who are refractory to standard-of-…

Objective Despite increased physician’s awareness and improved diagnostic and serological
testing in the recent years, the interval between the initial symptoms and the diagnosis of …

Background Mobile medical applications (Apps) offer innovative solutions for patients’ self-monitoring
and new patient management opportunities. Prior to routine clinical application …

Objectives Vaccinations are an important measure to prevent infections in immunocompromised
patients. The knowledge of vaccination coverage and reasons for non-vaccination in …

Objective To provide an estimate of age-specific incidence rate of physician-diagnosed
systemic lupus erythematosus (SLE) for German men and women. Methods The age-specific …

Background Multimorbidity raises the number of essential information needed for delivery of
high-quality care in patients with chronic diseases like rheumatoid arthritis (RA). We …

A few decades ago, the therapy goal of patients with systemic lupus erythematosus (SLE)
was survival and the prevention of organ failure. Today, clinical remission and low disease …

Objective. Intravenous cyclophosphamide (IV CYC) in combination with high doses of
corticosteroids is considered the “gold standard” of therapy for lupus nephritis (LN). However, the …

Objective Hypomethylation of CD40-ligand (CD40L) in T-cells is associated with increased
disease activity in systemic lupus erythematosus (SLE). We therefore investigated possible …

Objective To compare physician and patient assessments of global disease activity in anti-neutrophil
cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and to identify associated …